Radius Health Company Profile (NASDAQ:RDUS)

About Radius Health

Radius Health logoRadius Health, Inc. is a science-driven biopharmaceutical company focused on developing therapeutics for patients with osteoporosis, oncology and endocrine diseases. The Company's lead product candidate is the investigational drug abaloparatide for subcutaneous injection (abaloparatide-SC), which has completed Phase III development for potential use in the reduction of fracture risk in postmenopausal women with osteoporosis. Its abaloparatide-SC is under regulatory review in Europe. Its clinical pipeline also includes an investigational abaloparatide transdermal patch for potential use in osteoporosis, and the investigational drug RAD1901 for potential use in hormone-driven and/or hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its preclinical pipeline includes RAD140, which is an orally bioavailable non-steroidal, selective androgen receptor modulator (SARM). RAD140 is under investigation for potential applications in oncology and multiple conditions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: RDUS
  • CUSIP:
Key Metrics:
  • Previous Close: $54.65
  • 50 Day Moving Average: $47.69
  • 200 Day Moving Average: $37.45
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -15.10
  • P/E Growth: -4.79
  • Market Cap: $2.35B
  • Outstanding Shares: 43,082,000
  • Beta: 1.35
Additional Links:
Companies Related to Radius Health:

Analyst Ratings

Consensus Ratings for Radius Health (NASDAQ:RDUS) (?)
Ratings Breakdown: 1 Sell Rating, 2 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $59.50 (8.87% upside)

Analysts' Ratings History for Radius Health (NASDAQ:RDUS)
DateFirmActionRatingPrice TargetDetails
8/15/2016Jefferies GroupBoost Price TargetHold$37.00 -> $46.00View Rating Details
8/5/2016JPMorgan Chase & Co.Reiterated RatingBuy$70.00View Rating Details
8/4/2016Cowen and CompanyReiterated RatingBuyView Rating Details
8/4/2016Maxim GroupDowngradeHold -> Sell$24.00View Rating Details
5/31/2016Canaccord GenuityReiterated RatingBuyView Rating Details
5/23/2016HC WainwrightInitiated CoverageBuy$55.00View Rating Details
3/31/2016Cantor FitzgeraldReiterated RatingBuy$70.00View Rating Details
3/30/2016Goldman Sachs Group Inc.Initiated CoverageNeutral$37.00View Rating Details
1/25/2016Bank of America Corp.Reiterated RatingBuy$89.00View Rating Details
8/14/2015Deutsche Bank AGInitiated CoverageBuy$90.00View Rating Details
(Data available from 8/25/2014 forward)


Earnings History for Radius Health (NASDAQ:RDUS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.95)($1.01)ViewN/AView Earnings Details
5/5/2016Q116($0.74)($0.94)ViewN/AView Earnings Details
2/25/2016Q415($0.64)($0.77)ViewListenView Earnings Details
11/5/2015Q315($0.58)($0.68)ViewN/AView Earnings Details
8/6/2015Q215($0.52)($0.61)ViewN/AView Earnings Details
5/6/2015Q115($0.52)($0.47)ViewN/AView Earnings Details
3/10/2015Q414($0.63)($0.55)ViewN/AView Earnings Details
11/10/2014Q314($0.65)($0.59)ViewN/AView Earnings Details
8/12/2014Q2($0.89)($2.22)$16.24 million$10.62 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Radius Health (NASDAQ:RDUS)
Current Year EPS Consensus Estimate: $-4.08 EPS
Next Year EPS Consensus Estimate: $-3.62 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.80)($0.79)($0.80)
Q2 20161($0.99)($0.99)($0.99)
Q3 20161($1.05)($1.05)($1.05)
Q4 20161($1.02)($1.02)($1.02)
(Data provided by Zacks Investment Research)


Dividend History for Radius Health (NASDAQ:RDUS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Radius Health (NASDAQ:RDUS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/22/2016Growth N V BiotechMajor ShareholderBuy38,259$31.67$1,211,662.53View SEC Filing  
1/13/2016Growth N V BiotechMajor ShareholderBuy50,000$39.90$1,995,000.00View SEC Filing  
11/12/2015Gary HattersleyinsiderSell5,683$75.00$426,225.00View SEC Filing  
11/3/2015Gary HattersleyinsiderSell13,333$70.00$933,310.00View SEC Filing  
10/23/2015Gary HattersleyinsiderSell11,302$65.00$734,630.00View SEC Filing  
10/21/2015Gary HattersleyinsiderSell1,501$65.36$98,105.36View SEC Filing  
10/21/2015Rob WardCEOSell50,000$61.99$3,099,500.00View SEC Filing  
8/21/2015Growth N. V. Biotechmajor shareholderBuy100,000$64.00$6,400,000.00View SEC Filing  
8/17/2015Kurt GravesDirectorSell22,694$70.00$1,588,580.00View SEC Filing  
7/6/2015Kurt GravesDirectorSell25,000$69.48$1,737,000.00View SEC Filing  
6/18/2015Kurt GravesDirectorSell25,000$55.05$1,376,250.00View SEC Filing  
5/1/2015Growth N V BiotechMajor ShareholderBuy50,000$36.46$1,823,000.00View SEC Filing  
4/29/2015Growth N V BiotechMajor ShareholderBuy50,000$36.23$1,811,500.00View SEC Filing  
4/28/2015Growth N V BiotechMajor ShareholderBuy50,000$36.59$1,829,500.00View SEC Filing  
4/27/2015Growth N V BiotechMajor ShareholderBuy50,000$38.38$1,919,000.00View SEC Filing  
3/6/2015Growth N V BiotechMajor ShareholderBuy75,000$47.08$3,531,000.00View SEC Filing  
2/25/2015Growth N V BiotechMajor ShareholderBuy35,000$45.74$1,600,900.00View SEC Filing  
6/11/2014Morana Jovan-EmbiricosDirectorBuy587,500$8.00$4,700,000.00View SEC Filing  
6/6/2014Growth N V BiotechMajor ShareholderBuy1,000,000$8.00$8,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Radius Health (NASDAQ:RDUS)
fool.com logo3 Biotech Stocks With Explosive Upside Potential (NASDAQ:RDUS)
www.fool.com - August 23 at 7:10 PM
News IconStocks Buzz: Radius Health Inc (NASDAQ:RDUS), Cerulean Pharma Inc (NASDAQ:CERU) - Post Registrar (NASDAQ:RDUS)
postregistrar.com - August 22 at 6:59 PM
investornewswire.com logoWill Radius Health, Inc. (NASDAQ:RDUS) Hit $70 Price Target? - Investor Newswire (NASDAQ:RDUS)
www.investornewswire.com - August 21 at 6:15 PM
finance.yahoo.com logoRADIUS HEALTH, INC. Financials (NASDAQ:RDUS)
finance.yahoo.com - August 18 at 7:20 PM
4-traders.com logoRadius Health : RDUS) Announces Positive Results of Phase 3 ACTIVE Trial Published in JAMA (NASDAQ:RDUS)
www.4-traders.com - August 18 at 10:04 AM
istreetwire.com logoThree Movers to Watch for: Radius Health, Inc. (RDUS), Deere & Company (DE), Sophiris Bio, Inc. (SPHS) - iStreetWire (NASDAQ:RDUS)
istreetwire.com - August 17 at 7:24 PM
streetinsider.com logoRadius Health (RDUS) Announces Publication of Positive Phase 3 ACTIVE Data in JAMA - StreetInsider.com (NASDAQ:RDUS)
www.streetinsider.com - August 17 at 10:03 AM
finance.yahoo.com logoRadius (RDUS) Osteoporosis Drug Positive in Phase III Study (NASDAQ:RDUS)
finance.yahoo.com - August 17 at 10:03 AM
4-traders.com logoRadius Health : JAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With Osteoporosis (NASDAQ:RDUS)
www.4-traders.com - August 16 at 7:10 PM
finance.yahoo.com logo11:01 am Radius Health announces that positive results from the Phase 3 ACTIVE trial were published in the Journal of the American Medical Association (NASDAQ:RDUS)
finance.yahoo.com - August 16 at 7:10 PM
finance.yahoo.com logoJAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With Osteoporosis (NASDAQ:RDUS)
finance.yahoo.com - August 16 at 7:10 PM
News IconNews review of 2 biotech stocks: Radius Health, Inc. (NASDAQ:RDUS), ImmunoCellular Therapeutics, Ltd. (NYSEMKT ... - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - August 13 at 9:55 AM
investors.com logoRadius Health shares rise 10% on continued bid rumours (NASDAQ:RDUS)
www.proactiveinvestors.com - August 12 at 7:11 PM
News IconRadius Health Inc (NASDAQ:RDUS): Buying The Stock At Right Time In Important, We Bought At $39 (NASDAQ:RDUS)
www.marketnewscall.com - August 12 at 7:11 PM
thestreet.com logoRadius Health, Subject of Takeover Talk, Rises Again (NASDAQ:RDUS)
www.thestreet.com - August 10 at 10:11 AM
biz.yahoo.com logoRADIUS HEALTH, INC. Files SEC form 10-Q/A, Quarterly Report (NASDAQ:RDUS)
biz.yahoo.com - August 9 at 7:22 PM
News IconActive biotech company shares in the news: Radius Health, Inc. (NASDAQ:RDUS), ImmunoGen, Inc. (NASDAQ:IMGN) - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - August 8 at 11:48 AM
investornewswire.com logoStrong Sell Calls For Radius Health, Inc. (NASDAQ:RDUS) At 1 - Investor Newswire (NASDAQ:RDUS)
www.investornewswire.com - August 7 at 6:43 PM
News IconRadius Health Inc (NASDAQ:RDUS): It’s All About Timing To Make Massive Profit, Members Up In Short Term (NASDAQ:RDUS)
www.marketnewscall.com - August 6 at 9:48 AM
proactiveinvestors.co.uk logoMarket sees slow gains as oil climbs out of bear territory (NASDAQ:RDUS)
www.proactiveinvestors.co.uk - August 5 at 7:17 PM
finance.yahoo.com logoRadius Health (RDUS) Reports Wider-than-Expected Q2 Loss (NASDAQ:RDUS)
finance.yahoo.com - August 5 at 7:17 PM
finance.yahoo.com logoEdited Transcript of RDUS earnings conference call or presentation 4-Aug-16 12:00pm GMT (NASDAQ:RDUS)
finance.yahoo.com - August 5 at 7:17 PM
News IconTrading the Biotech News: Intrexon Corporation (NYSE:XON ... - The Voice Registrar (NASDAQ:RDUS)
voiceregistrar.com - August 5 at 10:07 AM
istreetwire.com logoStocks In Queue: American Eagle Outfitters, Inc. (AEO), Radius ... - iStreetWire (NASDAQ:RDUS)
istreetwire.com - August 4 at 7:35 PM
finance.yahoo.com logoRadius Health downgraded by Maxim Group (NASDAQ:RDUS)
finance.yahoo.com - August 4 at 7:35 PM
equities.com logoRadius Health Inc. (RDUS) is Trading Higher on Unusual Volume for August 02 - Equities.com (NASDAQ:RDUS)
www.equities.com - August 4 at 10:17 AM
sg.finance.yahoo.com logoRadius Health reports 2Q loss (NASDAQ:RDUS)
sg.finance.yahoo.com - August 4 at 10:17 AM
publicnow.com logoRadius Health Reports Second Quarter 2016 Financial and Operating Results (NASDAQ:RDUS)
www.publicnow.com - August 4 at 10:17 AM
biz.yahoo.com logoRADIUS HEALTH, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (NASDAQ:RDUS)
biz.yahoo.com - August 4 at 10:17 AM
biz.yahoo.com logoQ2 2016 Radius Health Inc Earnings Release - Before Market Open (NASDAQ:RDUS)
biz.yahoo.com - August 4 at 10:17 AM
finance.yahoo.com logoRadius Health (RDUS) Posts Wider-than-Expected Q2 Loss (NASDAQ:RDUS)
finance.yahoo.com - August 4 at 10:17 AM
istreetwire.com logoTrader's Buzzers: Radius Health (RDUS), New York REIT (NYRT), U.S. Silica (SLCA) - iStreetWire (NASDAQ:RDUS)
istreetwire.com - August 3 at 7:27 PM
News IconRadius Health Inc (NASDAQ:RDUS): That’s How Our members Made 40% In Just 4 weeks, Bought At $39 (NASDAQ:RDUS)
www.marketnewscall.com - August 3 at 10:22 AM
finance.yahoo.com logoWhat Awaits Radius Health (RDUS) this Earnings Season? (NASDAQ:RDUS)
finance.yahoo.com - August 2 at 12:03 PM
finance.yahoo.com logoRadius Health to Present at the 36th Annual Canaccord Genuity Growth Conference (NASDAQ:RDUS)
finance.yahoo.com - August 2 at 12:03 PM
tradecalls.org logoRadius Health (RDUS) Shares are Up 12.17% - Trade Calls (NASDAQ:RDUS)
www.tradecalls.org - July 25 at 7:14 PM
investornewswire.com logoIs $70 Price Target Attainable For Radius Health, Inc. (NASDAQ:RDUS)? - Investor Newswire (NASDAQ:RDUS)
www.investornewswire.com - July 24 at 11:10 AM
News IconIncreased Volatility Noted on Shares of: Radius Health, Inc. (NASDAQ:RDUS) - Engelwood Daily (NASDAQ:RDUS)
www.engelwooddaily.com - July 23 at 10:56 AM
nasdaq.com logoCommit To Purchase Radius Health At $22.50, Earn 8.9% Annualized Using Options (NASDAQ:RDUS)
www.nasdaq.com - July 22 at 6:54 PM
News IconIs Radius Health Inc a Buy? The Stock Rises Again - Consumer Eagle (NASDAQ:RDUS)
www.consumereagle.com - July 22 at 10:00 AM
News IconRadius Health, Inc. (NASDAQ:RDUS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:RDUS)
www.engelwooddaily.com - July 22 at 10:00 AM
News IconEquity Roundup: Stock Performance Focus on Radius Health, Inc. (NASDAQ:RDUS) - Press Telegraph (NASDAQ:RDUS)
presstelegraph.com - July 22 at 10:00 AM
News IconRadius Health Incorporated (NASDAQ:RDUS) Sellers Covered 2.52% of Their Shorts - Press Telegraph (NASDAQ:RDUS)
presstelegraph.com - July 22 at 10:00 AM
finance.yahoo.com logoRadius Health Announces Multiple Presentations at the American Society for Bone and Mineral Research 2016 Annual Meeting September 16-19, 2016 (NASDAQ:RDUS)
finance.yahoo.com - July 20 at 4:20 PM
streetinsider.com logoRadius Health (RDUS) Enters Manufacturing Services Agreement Lonza Sales - StreetInsider.com (NASDAQ:RDUS)
www.streetinsider.com - July 20 at 9:55 AM
News IconShares Positive Over the Past Month: Radius Health, Inc. (NASDAQ:RDUS) - TGP (NASDAQ:RDUS)
telanaganapress.com - July 20 at 9:55 AM
News IconShares Moving Down on the Week: Radius Health, Inc. (NASDAQ:RDUS) - Engelwood Daily (NASDAQ:RDUS)
www.engelwooddaily.com - July 17 at 6:28 PM
News IconShares Experiencing a Downtrend: Radius Health, Inc. (NASDAQ:RDUS) - TGP (NASDAQ:RDUS)
telanaganapress.com - July 16 at 10:20 AM
twst.com logoRadius Health Inc.: Radius Health to Announce Second Quarter 2016 Financial Results, Host Conference Call and ... - The Wall Street Transcript (NASDAQ:RDUS)
www.twst.com - July 16 at 10:20 AM
News IconTrading Performance and Target Watch for Radius Health, Inc. (NASDAQ:RDUS) - Press Telegraph (NASDAQ:RDUS)
presstelegraph.com - July 15 at 6:04 PM


Radius Health (NASDAQ:RDUS) Chart for Thursday, August, 25, 2016

Last Updated on 8/25/2016 by MarketBeat.com Staff